ZA93210B - Specific 1,4-dihydropyridine-3, 5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use. - Google Patents
Specific 1,4-dihydropyridine-3, 5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use.Info
- Publication number
- ZA93210B ZA93210B ZA93210A ZA93210A ZA93210B ZA 93210 B ZA93210 B ZA 93210B ZA 93210 A ZA93210 A ZA 93210A ZA 93210 A ZA93210 A ZA 93210A ZA 93210 B ZA93210 B ZA 93210B
- Authority
- ZA
- South Africa
- Prior art keywords
- dihydropyridine
- preparation
- specific
- acid ester
- dicarboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4200714A DE4200714A1 (de) | 1992-01-14 | 1992-01-14 | Spezieller 1,4-dihydropyridin-3,5-dicarbonsaeureester, verfahren zu seiner herstellung und seine pharmazeutische verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA93210B true ZA93210B (en) | 1993-09-09 |
Family
ID=6449473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA93210A ZA93210B (en) | 1992-01-14 | 1993-01-13 | Specific 1,4-dihydropyridine-3, 5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5342847A (hu) |
EP (1) | EP0551663A1 (hu) |
JP (1) | JPH0616633A (hu) |
KR (1) | KR930016399A (hu) |
CN (1) | CN1075141A (hu) |
AU (1) | AU3108393A (hu) |
CA (1) | CA2087245A1 (hu) |
CZ (1) | CZ396492A3 (hu) |
DE (1) | DE4200714A1 (hu) |
HU (1) | HUT70155A (hu) |
IL (1) | IL104357A0 (hu) |
MX (1) | MX9300057A (hu) |
PL (1) | PL297393A1 (hu) |
ZA (1) | ZA93210B (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4223867A1 (de) * | 1992-07-20 | 1994-01-27 | Bayer Ag | Spezieller 1,4-Dihydropyridin-3,5-dicarbonsäureester, Verfahren zu seiner Herstellung und seine pharmazeutische Verwendung |
CH692199A8 (fr) * | 1997-10-09 | 2002-06-14 | Cermol S.A. | Composes pyridiques et compositions pharmaceutique |
CN102453242B (zh) * | 2010-10-27 | 2013-05-22 | 中国科学院大连化学物理研究所 | 一种直接酯化聚合制备聚呋喃二甲酸酯的方法 |
WO2013076516A1 (en) * | 2011-11-24 | 2013-05-30 | Lipidart Kutató Fejlesztő És Tanácsadó Kft. | 1,4- dihydropyridine derivatives with hsp modulating activity |
CN103044316A (zh) * | 2013-01-23 | 2013-04-17 | 石家庄学院 | 一种以咪唑离子液体为催化剂制备1,4-二氢吡啶的方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3883543A (en) * | 1969-05-10 | 1975-05-13 | Bayer Ag | N-alkyl-1,4-dihydropyridines |
DE2210667A1 (de) * | 1972-03-06 | 1973-09-20 | Bayer Ag | Kondensiert aromatisch substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
US3956341A (en) * | 1974-02-21 | 1976-05-11 | Smithkline Corporation | 1,3,5-Tricarbo-1,4-dihydropyridines |
ATE107284T1 (de) * | 1984-09-28 | 1994-07-15 | Byk Gulden Lomberg Chem Fab | Neue diarylverbindungen. |
US4975440A (en) * | 1984-09-28 | 1990-12-04 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Optically-active 1,4-dihydropyridine |
US4771057A (en) * | 1986-02-03 | 1988-09-13 | University Of Alberta | Reduced pyridyl derivatives with cardiovascular regulating properties |
US4780538A (en) * | 1986-02-12 | 1988-10-25 | Merck & Co., Inc. | Process for 1,4-dihydropyridine compounds using a titanamine catalyst |
DE4011695A1 (de) * | 1990-04-11 | 1991-10-17 | Bayer Ag | Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung |
-
1992
- 1992-01-14 DE DE4200714A patent/DE4200714A1/de not_active Withdrawn
- 1992-12-29 CZ CS923964A patent/CZ396492A3/cs unknown
- 1992-12-31 EP EP92122179A patent/EP0551663A1/de not_active Withdrawn
-
1993
- 1993-01-07 AU AU31083/93A patent/AU3108393A/en not_active Abandoned
- 1993-01-08 MX MX9300057A patent/MX9300057A/es unknown
- 1993-01-11 IL IL104357A patent/IL104357A0/xx unknown
- 1993-01-12 PL PL29739393A patent/PL297393A1/xx unknown
- 1993-01-13 HU HU9300075A patent/HUT70155A/hu unknown
- 1993-01-13 KR KR1019930000354A patent/KR930016399A/ko not_active Application Discontinuation
- 1993-01-13 CA CA002087245A patent/CA2087245A1/en not_active Abandoned
- 1993-01-13 ZA ZA93210A patent/ZA93210B/xx unknown
- 1993-01-13 JP JP5019454A patent/JPH0616633A/ja active Pending
- 1993-01-14 CN CN93101011A patent/CN1075141A/zh active Pending
- 1993-01-16 US US08/001,017 patent/US5342847A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH0616633A (ja) | 1994-01-25 |
US5342847A (en) | 1994-08-30 |
CA2087245A1 (en) | 1993-07-15 |
HU9300075D0 (en) | 1993-04-28 |
CZ396492A3 (en) | 1993-12-15 |
DE4200714A1 (de) | 1993-07-15 |
EP0551663A1 (de) | 1993-07-21 |
MX9300057A (es) | 1993-09-01 |
KR930016399A (ko) | 1993-08-26 |
IL104357A0 (en) | 1993-05-13 |
AU3108393A (en) | 1993-07-15 |
HUT70155A (en) | 1995-09-28 |
PL297393A1 (en) | 1993-10-04 |
CN1075141A (zh) | 1993-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9400413D0 (en) | Imidazoly-alcenoic acids, pharmaceutical compositions containing them, and process for producing them | |
EP0798285A3 (en) | 3,4,4-Trifluoro-3-butenoic acid or its methyl ester | |
IL107221A0 (en) | Carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their preparation | |
EP0494654A3 (en) | Stable pharmaceutical composition and method for its production | |
IL107956A0 (en) | Carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
HUT53362A (en) | Process for producing substituted 1,3-oxathiolans and pharmaceutical compositions comprising same | |
IL100899A0 (en) | Beta-amino-alpha-hydroxycarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUT63632A (en) | Process for producing 5-amino-4-hydroxyhexanoic acid derivatives and pharmaceutical compositions comprising same | |
IL99030A0 (en) | 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
NZ213461A (en) | 1,4-dihyrdropyridine-3,5-dicarboxylic acid derivatives and pharmaceutical compositions | |
IL101771A0 (en) | Carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them | |
NZ231353A (en) | Pharmaceutical compositions comprising 3,5-dihydroxy-7-(1-acyloxyhexahydronaphth-8-yl)-heptanoic acid and lactone derivatives | |
PH31073A (en) | Pharmaceutical composition and process for the preparation thereof. | |
IL102362A0 (en) | 4-amino-3-hydroxycarboxylic acid derivatives,their production and pharmaceutical compositions containing them | |
HUT72319A (en) | Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation | |
ZA93210B (en) | Specific 1,4-dihydropyridine-3, 5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use. | |
IL95210A0 (en) | 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same | |
IL108930A0 (en) | 2,3-Diamino-3- hydroxycarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
IL105391A0 (en) | 1,2,4-benzothiadiazine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
ZA935191B (en) | Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester, process for its preparation and its pharmaceutical use. | |
NZ218614A (en) | 16,17-butylidenedioxy-6,9-difluoro-11-hydroxy-3, 20-dioxopregna-1,4-diene-21-oic acid esters and pharmaceutical compositions | |
IL82294A (en) | 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL101476A0 (en) | Optically-active carboxylic acids,processes for the preparation thereof and pharmaceutical compositions containing them | |
IL115030A0 (en) | Use of 1,4-dihydropyridine - 3,5-dicarboxylic acid esters as medicaments | |
HUT68249A (en) | 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor and pharmaceutical composition containing it and process for producing thereof |